fos promoter Search Results


c fos promoter  (Cell Signaling Technology Inc)
91
Cell Signaling Technology Inc c fos promoter
C Fos Promoter, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c fos promoter/product/Cell Signaling Technology Inc
Average 91 stars, based on 1 article reviews
c fos promoter - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier
fos promoter/luciferase construct  (Qiagen)
90
Qiagen fos promoter/luciferase construct
Fos Promoter/Luciferase Construct, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fos promoter/luciferase construct/product/Qiagen
Average 90 stars, based on 1 article reviews
fos promoter/luciferase construct - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
c-fos promoter  (DIAGENODE DIAGNOSTICS)
90
DIAGENODE DIAGNOSTICS c-fos promoter
Figure 2. RTT syndrome is associated with higher density of histone H3 and lower levels of histone H3 methylation on promoters in lymphocytes. ChIPs of histone H3 ( A ), histone H3, trimethylated on lysine 4 (H3K4me3) ( B ), histone H3 acetylated on lysine 9 (H3K9ac) ( C ), and histone H3 acetylated on lysine 27 (H3K27ac) ( D ) on BDNF promoters, DLX5 promoter, <t>C-FOS</t> promoter and Myglobin exon 2. H3K4me3 was significantly lower in RTT patient lymphocytes than control subjects whereas H3K9ac and H3K27ac modification ratio was not significantly altered. A trend toward lower acetylation ratio in RTT patients was noted.
C Fos Promoter, supplied by DIAGENODE DIAGNOSTICS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c-fos promoter/product/DIAGENODE DIAGNOSTICS
Average 90 stars, based on 1 article reviews
c-fos promoter - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
c-fos promoter  (Baier labs)
90
Baier labs c-fos promoter
Figure 2. RTT syndrome is associated with higher density of histone H3 and lower levels of histone H3 methylation on promoters in lymphocytes. ChIPs of histone H3 ( A ), histone H3, trimethylated on lysine 4 (H3K4me3) ( B ), histone H3 acetylated on lysine 9 (H3K9ac) ( C ), and histone H3 acetylated on lysine 27 (H3K27ac) ( D ) on BDNF promoters, DLX5 promoter, <t>C-FOS</t> promoter and Myglobin exon 2. H3K4me3 was significantly lower in RTT patient lymphocytes than control subjects whereas H3K9ac and H3K27ac modification ratio was not significantly altered. A trend toward lower acetylation ratio in RTT patients was noted.
C Fos Promoter, supplied by Baier labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c-fos promoter/product/Baier labs
Average 90 stars, based on 1 article reviews
c-fos promoter - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
c-fos promoter transcriptional activity  (Inserm Transfert)
90
Inserm Transfert c-fos promoter transcriptional activity
Figure 2. RTT syndrome is associated with higher density of histone H3 and lower levels of histone H3 methylation on promoters in lymphocytes. ChIPs of histone H3 ( A ), histone H3, trimethylated on lysine 4 (H3K4me3) ( B ), histone H3 acetylated on lysine 9 (H3K9ac) ( C ), and histone H3 acetylated on lysine 27 (H3K27ac) ( D ) on BDNF promoters, DLX5 promoter, <t>C-FOS</t> promoter and Myglobin exon 2. H3K4me3 was significantly lower in RTT patient lymphocytes than control subjects whereas H3K9ac and H3K27ac modification ratio was not significantly altered. A trend toward lower acetylation ratio in RTT patients was noted.
C Fos Promoter Transcriptional Activity, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c-fos promoter transcriptional activity/product/Inserm Transfert
Average 90 stars, based on 1 article reviews
c-fos promoter transcriptional activity - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
firefly luciferase reporter plasmid p5xuas-c-fos-promoter-luc  (Promega)
90
Promega firefly luciferase reporter plasmid p5xuas-c-fos-promoter-luc
Figure 2. RTT syndrome is associated with higher density of histone H3 and lower levels of histone H3 methylation on promoters in lymphocytes. ChIPs of histone H3 ( A ), histone H3, trimethylated on lysine 4 (H3K4me3) ( B ), histone H3 acetylated on lysine 9 (H3K9ac) ( C ), and histone H3 acetylated on lysine 27 (H3K27ac) ( D ) on BDNF promoters, DLX5 promoter, <t>C-FOS</t> promoter and Myglobin exon 2. H3K4me3 was significantly lower in RTT patient lymphocytes than control subjects whereas H3K9ac and H3K27ac modification ratio was not significantly altered. A trend toward lower acetylation ratio in RTT patients was noted.
Firefly Luciferase Reporter Plasmid P5xuas C Fos Promoter Luc, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/firefly luciferase reporter plasmid p5xuas-c-fos-promoter-luc/product/Promega
Average 90 stars, based on 1 article reviews
firefly luciferase reporter plasmid p5xuas-c-fos-promoter-luc - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
fos promoter fos-40 luc  (Promega)
90
Promega fos promoter fos-40 luc
Figure 2. RTT syndrome is associated with higher density of histone H3 and lower levels of histone H3 methylation on promoters in lymphocytes. ChIPs of histone H3 ( A ), histone H3, trimethylated on lysine 4 (H3K4me3) ( B ), histone H3 acetylated on lysine 9 (H3K9ac) ( C ), and histone H3 acetylated on lysine 27 (H3K27ac) ( D ) on BDNF promoters, DLX5 promoter, <t>C-FOS</t> promoter and Myglobin exon 2. H3K4me3 was significantly lower in RTT patient lymphocytes than control subjects whereas H3K9ac and H3K27ac modification ratio was not significantly altered. A trend toward lower acetylation ratio in RTT patients was noted.
Fos Promoter Fos 40 Luc, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fos promoter fos-40 luc/product/Promega
Average 90 stars, based on 1 article reviews
fos promoter fos-40 luc - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
human c-fos gene promoter sequence  (Yingrun Biotechnologies Inc)
90
Yingrun Biotechnologies Inc human c-fos gene promoter sequence
Figure 2. RTT syndrome is associated with higher density of histone H3 and lower levels of histone H3 methylation on promoters in lymphocytes. ChIPs of histone H3 ( A ), histone H3, trimethylated on lysine 4 (H3K4me3) ( B ), histone H3 acetylated on lysine 9 (H3K9ac) ( C ), and histone H3 acetylated on lysine 27 (H3K27ac) ( D ) on BDNF promoters, DLX5 promoter, <t>C-FOS</t> promoter and Myglobin exon 2. H3K4me3 was significantly lower in RTT patient lymphocytes than control subjects whereas H3K9ac and H3K27ac modification ratio was not significantly altered. A trend toward lower acetylation ratio in RTT patients was noted.
Human C Fos Gene Promoter Sequence, supplied by Yingrun Biotechnologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human c-fos gene promoter sequence/product/Yingrun Biotechnologies Inc
Average 90 stars, based on 1 article reviews
human c-fos gene promoter sequence - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
fos promoter  (Inserm Transfert)
90
Inserm Transfert fos promoter
Figure 2. RTT syndrome is associated with higher density of histone H3 and lower levels of histone H3 methylation on promoters in lymphocytes. ChIPs of histone H3 ( A ), histone H3, trimethylated on lysine 4 (H3K4me3) ( B ), histone H3 acetylated on lysine 9 (H3K9ac) ( C ), and histone H3 acetylated on lysine 27 (H3K27ac) ( D ) on BDNF promoters, DLX5 promoter, <t>C-FOS</t> promoter and Myglobin exon 2. H3K4me3 was significantly lower in RTT patient lymphocytes than control subjects whereas H3K9ac and H3K27ac modification ratio was not significantly altered. A trend toward lower acetylation ratio in RTT patients was noted.
Fos Promoter, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fos promoter/product/Inserm Transfert
Average 90 stars, based on 1 article reviews
fos promoter - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
plasmid carrying a minimal c-fos promoter driving luciferase expression (fopflash)  (Johns Hopkins HealthCare)
90
Johns Hopkins HealthCare plasmid carrying a minimal c-fos promoter driving luciferase expression (fopflash)
Figure 2. RTT syndrome is associated with higher density of histone H3 and lower levels of histone H3 methylation on promoters in lymphocytes. ChIPs of histone H3 ( A ), histone H3, trimethylated on lysine 4 (H3K4me3) ( B ), histone H3 acetylated on lysine 9 (H3K9ac) ( C ), and histone H3 acetylated on lysine 27 (H3K27ac) ( D ) on BDNF promoters, DLX5 promoter, <t>C-FOS</t> promoter and Myglobin exon 2. H3K4me3 was significantly lower in RTT patient lymphocytes than control subjects whereas H3K9ac and H3K27ac modification ratio was not significantly altered. A trend toward lower acetylation ratio in RTT patients was noted.
Plasmid Carrying A Minimal C Fos Promoter Driving Luciferase Expression (Fopflash), supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plasmid carrying a minimal c-fos promoter driving luciferase expression (fopflash)/product/Johns Hopkins HealthCare
Average 90 stars, based on 1 article reviews
plasmid carrying a minimal c-fos promoter driving luciferase expression (fopflash) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
primers designed to amplify the c-fos gene promoter  (DIAGENODE DIAGNOSTICS)
90
DIAGENODE DIAGNOSTICS primers designed to amplify the c-fos gene promoter
Figure 2. RTT syndrome is associated with higher density of histone H3 and lower levels of histone H3 methylation on promoters in lymphocytes. ChIPs of histone H3 ( A ), histone H3, trimethylated on lysine 4 (H3K4me3) ( B ), histone H3 acetylated on lysine 9 (H3K9ac) ( C ), and histone H3 acetylated on lysine 27 (H3K27ac) ( D ) on BDNF promoters, DLX5 promoter, <t>C-FOS</t> promoter and Myglobin exon 2. H3K4me3 was significantly lower in RTT patient lymphocytes than control subjects whereas H3K9ac and H3K27ac modification ratio was not significantly altered. A trend toward lower acetylation ratio in RTT patients was noted.
Primers Designed To Amplify The C Fos Gene Promoter, supplied by DIAGENODE DIAGNOSTICS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primers designed to amplify the c-fos gene promoter/product/DIAGENODE DIAGNOSTICS
Average 90 stars, based on 1 article reviews
primers designed to amplify the c-fos gene promoter - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
growth-promoting supplement fos  (MiddleBrook Pharmaceuticals)
90
MiddleBrook Pharmaceuticals growth-promoting supplement fos
Figure 2. RTT syndrome is associated with higher density of histone H3 and lower levels of histone H3 methylation on promoters in lymphocytes. ChIPs of histone H3 ( A ), histone H3, trimethylated on lysine 4 (H3K4me3) ( B ), histone H3 acetylated on lysine 9 (H3K9ac) ( C ), and histone H3 acetylated on lysine 27 (H3K27ac) ( D ) on BDNF promoters, DLX5 promoter, <t>C-FOS</t> promoter and Myglobin exon 2. H3K4me3 was significantly lower in RTT patient lymphocytes than control subjects whereas H3K9ac and H3K27ac modification ratio was not significantly altered. A trend toward lower acetylation ratio in RTT patients was noted.
Growth Promoting Supplement Fos, supplied by MiddleBrook Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/growth-promoting supplement fos/product/MiddleBrook Pharmaceuticals
Average 90 stars, based on 1 article reviews
growth-promoting supplement fos - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Figure 2. RTT syndrome is associated with higher density of histone H3 and lower levels of histone H3 methylation on promoters in lymphocytes. ChIPs of histone H3 ( A ), histone H3, trimethylated on lysine 4 (H3K4me3) ( B ), histone H3 acetylated on lysine 9 (H3K9ac) ( C ), and histone H3 acetylated on lysine 27 (H3K27ac) ( D ) on BDNF promoters, DLX5 promoter, C-FOS promoter and Myglobin exon 2. H3K4me3 was significantly lower in RTT patient lymphocytes than control subjects whereas H3K9ac and H3K27ac modification ratio was not significantly altered. A trend toward lower acetylation ratio in RTT patients was noted.

Journal: Epigenetics

Article Title: Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients

doi: 10.4161/epi.23752

Figure Lengend Snippet: Figure 2. RTT syndrome is associated with higher density of histone H3 and lower levels of histone H3 methylation on promoters in lymphocytes. ChIPs of histone H3 ( A ), histone H3, trimethylated on lysine 4 (H3K4me3) ( B ), histone H3 acetylated on lysine 9 (H3K9ac) ( C ), and histone H3 acetylated on lysine 27 (H3K27ac) ( D ) on BDNF promoters, DLX5 promoter, C-FOS promoter and Myglobin exon 2. H3K4me3 was significantly lower in RTT patient lymphocytes than control subjects whereas H3K9ac and H3K27ac modification ratio was not significantly altered. A trend toward lower acetylation ratio in RTT patients was noted.

Article Snippet: C-FOS promoter , Diagenode primers , .

Techniques: Methylation, Modification

Figure 3. No significant differences were seen in density of histones H1 and H2B between RTT patient lymphocytes and control subjects. No significant differences were seen in occupancy of S5P-RNAP II or occupancy of MeCP2 between RTT patient lymphocytes and control subjects. ChIPs of histone H1 ( A ), histone H2B ( B ), S5P-RNAP II ( C ) and MeCP2 ( D ) on BDNF promoters, DLX5 promoter, C-FOS promoter and Myglobin exon 2.

Journal: Epigenetics

Article Title: Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients

doi: 10.4161/epi.23752

Figure Lengend Snippet: Figure 3. No significant differences were seen in density of histones H1 and H2B between RTT patient lymphocytes and control subjects. No significant differences were seen in occupancy of S5P-RNAP II or occupancy of MeCP2 between RTT patient lymphocytes and control subjects. ChIPs of histone H1 ( A ), histone H2B ( B ), S5P-RNAP II ( C ) and MeCP2 ( D ) on BDNF promoters, DLX5 promoter, C-FOS promoter and Myglobin exon 2.

Article Snippet: C-FOS promoter , Diagenode primers , .

Techniques:

Table 1. Primers used

Journal: Epigenetics

Article Title: Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients

doi: 10.4161/epi.23752

Figure Lengend Snippet: Table 1. Primers used

Article Snippet: C-FOS promoter , Diagenode primers , .

Techniques: